. slipped 0.6 per cent to Rs 439.0 in Monday’s trade as of 12:23PM (IST). It hit a high of Rs 444.95 and low of Rs 437.0 during the session.
The stock quoted a 52-week high price of Rs 742.25 and a low of Rs 437.0. The return on equity for the stock stood at 10.77 per cent. About 22,776 shares have changed hands on the counter so far.
The stock’s beta value, which measures its volatility in relation to the broader market, stood at 1.06.
The scrip has been an underperformer, down 35.38 per cent in the past one year in comparison with a 6.12 per cent gain in Sensex.
On the technical charts, the 200-day moving average (DMA) of the stock stood at Rs 437.0 on December 19, while the 50-DMA was at Rs 493.99. If a stock trades well above 50-DMA and 200-DMA, it usually means the immediate trend is upward. On the other hand, if the stock trades well below 50-DMA and 200-DMA both, it is considered a bearish trend and if trades between these averages, then it suggests the stock can go either way.
Promoters held 48.76 per cent stake in Aurobindo Pharma Ltd. as of 30-Sep-2022. Mutual funds and foreign institutional investors held 9.82 per cent and 20.71 per cent stake.
(What’s moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
Download The Economic Times News App to get Daily Market Updates & Live Business News.